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Dendritic cells (DCs), especially plasmacytoid DCs (pDCs), produce large amounts of alpha/beta interferon (IFN-/) upon
infection with DNA or RNA viruses, which has impacts on the physiopathology of the viral infections and on the quality of the
adaptive immunity. However, little is known about the IFN-/ production by DCs during infections by double-stranded RNA
(dsRNA) viruses. We present here novel information about the production of IFN-/ induced by bluetongue virus (BTV), a
vector-borne dsRNAOrbivirus of ruminants, in sheep primary DCs.We found that BTV induced IFN-/ in skin lymph and in
blood in vivo. Although BTV replicated in a substantial fraction of the conventional DCs (cDCs) and pDCs in vitro, only pDCs
responded to BTV by producing a significant amount of IFN-/. BTV replication in pDCs was not mandatory for IFN-/ pro-
duction since it was still induced by UV-inactivated BTV (UV-BTV). Other inflammatory cytokines, including tumor necrosis
factor alpha (TNF-), interleukin-6 (IL-6), and IL-12p40, were also induced by UV-BTV in primary pDCs. The induction of IFN-
/ required endo-/lysosomal acidification andmaturation. However, despite being an RNA virus, UV-BTV did not signal
through Toll-like receptor 7 (TLR7) for IFN-/ induction. In contrast, pathways involving theMyD88 adaptor and kinases
dsRNA-activated protein kinase (PKR) and stress-activated protein kinase (SAPK)/Jun N-terminal protein kinase (JNK) were
implicated. This work highlights the importance of pDCs for the production of innate immunity cytokines induced by a dsRNA
virus, and it shows that a dsRNA virus can induce IFN-/ in pDCs via a novel TLR-independent andMyd88-dependent path-
way. These findings have implications for the design of efficient vaccines against dsRNA viruses.
The Reoviridae are a family of nonenveloped double-strandedRNA (dsRNA) viruses that include reoviruses of clinical im-
portance, such as rotaviruses in humans and orbiviruses in ani-
mals. Inmany instances, the diseases induced by the reoviruses are
acute, showing high prevalence with variable degrees of severity
and mortality in immunologically naive populations. Among the
orbiviruses, bluetongue virus (BTV), which primarily infects ru-
minants, recently caused major outbreaks in many European
countries and induced large economic losses due to direct animal
disease and death, loss of productivity, restrictions on trade and
animal movements, and expensive surveillance and vaccination
campaigns (58). There are 26 distinct BTV serotypes (BTV1 to
BTV26) that induce serotype non-cross-protective immunity and
that have an impact on vaccination strategies.
The innate immune responses elicited by the dsRNA viruses,
including the production of type I interferon (alpha/beta inter-
feron [IFN-/]) and other inflammatory cytokines, are likely to
be key factors in the expression of their variable pathogenicity
levels (34). Different dsRNA sensors and signaling pathways have
been described that mediate the production of innate cytokines in
response to reovirus infections, including (i) the TLR3 (Toll-like
receptor 3)-TRIF (TIR [Toll–IL-1 {interleukin-1} resistance] do-
main-containing adaptor inducing IFN-) endosomal pathway
(1), (ii) the RIG-I (retinoid acid-inducible gene I) orMDA5 (mel-
anoma differentiation-associated gene 5)-MAVS (mitochondrial
antiviral signaling) mitochondrial pathway (6, 60, 68), (iii) the
PKR (dsRNA-activated protein kinase) pathway (18, 19, 60), and
(iv) the newly described TRIF-dependent DexD/H-box helicases
(69). These signaling pathways are involved in innate responses to
dsRNA virus in cell types such as fibroblasts, epithelial cells, and
conventional dendritic cells (cDCs). They also seem to be alterna-
tively used for sensing and signaling depending on the cell type
and on the subcellular compartment where they encounter the
dsRNA (6, 60, 69).
Although both hematopoietic and nonhematopoietic cells are
thought to be involved in the innate cytokine responses to dsRNA
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viruses in vivo, the use of hematopoietic mouse chimeras revealed
that hematopoietic cells, including both cDCs and plasmacytoid
DCs (pDC), play a key role in type I IFN production during or-
thoreovirus infection (34). Indeed, PDCs are the main hemato-
poietic cell type specialized in the production of innate cytokines
and, especially, of huge amounts of IFN-/. PDC responses to
viral triggers were studied in single-stranded RNA (ssRNA) and
DNA virus infections. TLR7 and TLR9 linked to theMyD88 adap-
tor molecule were demonstrated to be the major and possibly the
only innate receptors that activate this cell type. However, cytoso-
lic DexD/H-box helicases linked toMyD88 can also be involved in
viral DNA recognition in pDCs (36). Both orthoreovirus infection
inmice and rotavirus infection in human are capable of triggering
the production of IFN-/ in pDCs. However, as pDCs do not
express TLR3 (14, 48) and do not use the RIG-1/MDA5 signaling
pathway (35, 54, 63), it is still not known how pDCs respond to
dsRNA virus infection. In addition, very few studies have been
reported to date concerning the relative contribution of pDCs to
innate cytokine production in response to dsRNA virus infection.
In this study, we addressed the role of pDCs in IFN-/ pro-
duction in response to BTV compared to the role of other hema-
topoietic cells, including the cDCs that represent the initial cell
target for BTV replication after its injection into sheep skin. In
sheep, pDCs are rare cells found in blood (0.5%), and they also
circulate in skin lymph (52). Preliminary experiments in C57BL/6
mice indicated that murine hematopoietic cells and purified mu-
rine pDCs do not respond to BTV by producing IFN-/, pre-
venting the use of mouse models to address BTV signaling for
IFN-/ production.We therefore directly investigated the inter-
action of BTV with its natural sheep host pDCs and cDCs, and we
were able to use primary cells, due to the large quantities of cells
that can be collected in this species.
MATERIALS AND METHODS
Mediumand reagents.X-Vivo 15 (BioWhittaker) supplementedwith 1%
heat-inactivated fetal calf serum (FCS), 100 IU/ml penicillin, and 100
g/ml streptomycin was used as the cell culture medium for sheep cells.
RPMI 1640 supplemented with 4% horse serum (HS) was used for cell
immunolabeling (fluorescence-activated cell sorting [FACS] medium).
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10%
FCS, 100 IU/ml penicillin, and 100g/ml streptomycin was used for baby
hamster kidney-21 (BHK21) culture (virus growth and titration). Eagle’s
minimum essential medium (EMEM) supplemented with 5% FCS, 1.5
mM L-glutamine, 100 IU/ml penicillin, and 100 g/ml streptomycin was
used for Madin-Darby bovine kidney (MDBK) cell culture. CpG-A D32-
oligodeoxynucleotide with the sequence ggTGCGTCGACGCAG ggg gg
(lowercase letters for phosphothioate linkages and uppercase letters for
phosphodiester linkages) was produced by BioSource International.
Opti-MEM (Invitrogen) and Lipofectamine 2000 (Invitrogen) were used
for poly(I·C) (Sigma-Aldrich) transfection. 2-Aminopurine (2-AP), chlo-
roquine, and bafilomycin A1 were obtained from Sigma-Aldrich.
SP600125 (Jun N-terminal protein kinase [JNK] inhibitor) and PKR in-
hibitor (C16) were from Calbiochem (Merck), and PD184352 was from
AXON Medchem. The MyD88 homodimerization inhibitory peptide set
was purchased from Imgenex. TheA151 oligonucleotide [(TTAGGG)4], a
TLR7/9 antagonist (26), was synthesized at the Pasteur Institute Geno-
pole, Paris, France.
Virus preparations.Wild-type field strains of BTV serotypes 1, 2, and
8 (BTV1, BTV2, and BTV8) were isolated in France in 2007, 2001 (Cor-
sica), and 2006, respectively. These viruses are still virulent and patho-
genic in sheep. The modified live attenuated vaccine strain BTV2 (a-
BTV2) was produced by Onderstepoort Biological Products in the
Republic of South Africa. For purified BTV1, virus particles of the South
African reference strain of BTV1 were purified on sucrose gradients as
previously described by Mertens et al. (46). This strain of BTV is held in
the Institute for Animal Health (IAH, United Kingdom) reference collec-
tion (www.reoviridae.org/dsRNA_virus_proteins/ReoID/btv-1.htm) and
is identified by strain number RSArrrr/01.
Viruses were grown on BHK21 cells. For preparation of crude viral
stocks, confluent BHK21 cell layers were infected with 0.1 50% tissue
culture infective dose (TCID50)/cell and cells were incubated at 37°C and
5% CO2. When cytopathic effect was complete (4 to 5 days), culture su-
pernatants were aliquoted and stored at80°C. The TCID50 values were
estimated by the method of Spearman-Karber using a previously de-
scribed protocol (27).
Heat inactivation of BTV was done at 56°C for 30 min. For UV inac-
tivation, virus preparations (2ml) were exposed to 254-nmUVat a 10-cm
distance from the source in 35-mm-diameter dishes. Virus was com-
pletely inactivated (UV-BTV) in 20 min when the dose of UV was 2.3
J/cm2 (see Fig. S2 in the supplemental material). Formol-inactivated in-
fluenza virus (PR8/34) was prepared as previously described (61).
Animals and afferent lymph and blood collection. Prealpe BTV-se-
ronegative female sheep, originating from l’Unité Commune d’Expéri-
mentation Animale in Jouy-en-Josas, France, were cannulated at the Cen-
tre de Recherche en Imagerie Interventionnelle in Jouy-en-Josas as
previously described (23). Low-molecular-weight heparin (enoxaparin
[Lovenox], Sanofi-Aventis) was injected intradermally into the shoulder
skin every 12 h (2,000 IU anti-enoxaparin per injection). Lymph was
collected twice a day in flasks containing 500 IU heparin, 10,000 IU pen-
icillin, and 10 mg streptomycin. This protocol was carried out in strict
accordance with the recommendations of the Charte Nationale Portant
sur l’Éthique en Expérimentation Animale established by the Comité Na-
tional de Réflexion Éthique sur l’Expérimentation Animale (CNREEA,
Ministère de l’Enseignement Supérieur et de la Recherche et Ministère de
l’Agriculture et de la Pêche) and was approved by the Committee on the
Ethics of Animal Experiments of the INRA research center in Jouy-en-
Josas and AgroParisTech under the number 11-019. The animal experi-
ments were carried out under licenses issued by the Veterinary Services of
Versailles (accreditation numbers A78-93, A78-15, and A78-730).
Blood was collected from Prealpe sheep (1 to 4 years old) by venous
puncture on sodium citrate.
In vivo infections. Two cannulated sheep were inoculated intrader-
mally with 105 TCID50 a-BTV2 and BTV8, respectively, in the biosafety
level 3 (BSL3) animal facilities of the Centre de Recherche en Biologie
Médicale in Maisons-Alfort, France. Lymph draining the corresponding
area of the skin was harvested at different time points as indicated below,
and the sheep were terminated at the end of the experiment.
For IFN-/ detection in sera, BTV-seronegative Prealpe sheep were
infected subcutaneously and intravenously with, respectively, 1 and 5 ml
of blood from a viremic BTV8-infected animal (8.1  106 BTV RNA
copies/ml) in the BSL3 facilities of the Plate-Forme d’Infectiologie Expéri-
mentale inNouzilly, France. Serawere obtained from the infected animals
at 0, 2, 6, and 10 days after infection. The sheepwere terminated at the end
of the experiment.
Lowdensity (LD) lymph and LDperipheral bloodmononuclear cell
(PBMC) isolations.Total afferent lymph cells were spun down at 700 g,
and LD lymph cells were obtained after centrifugation on a 1.065-g/ml
iodixanol density gradient (OptiPrep, Nycomed Pharma) as previously
described (57).
PBMCswere obtained from sheep peripheral blood buffy coat samples
by 1.076-g/ml Percoll (GE Healthcare) density gradient centrifugation
(8). LD PBMCs were obtained after centrifugation on iodixanol gradient
as described for lymph cells.
In vitro activation of LD lymph cells, LD PBMCs, cDCs, and pDCs
with BTV and IFN-/ inducers and use of inhibitors. LD lymph cells,
LD PBMCs, and pDCs were incubated at 37°C with 0.01 to 0.5 TCID50
BTV/cell in cell culturemedium. The cell and viral concentrations used in
Ruscanu et al.
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each experiment are specified in the text and/or in the figure legends.
Generally a 0.06 TCID50 BTV/cell concentration was used with BTV8 and
lower concentrations were used when viral strain stocks were at lower
titers. For testing IFN-/ production in supernatants, cells were cultured
overnight with BTV. For detection of intracellular NS2 and surface
CD80/86 expression, cells were cultured for 48 h with BTV. For detection
of viral replication in pDCs by quantitative reverse transcriptase PCR
(qRT-PCR), FACS-sorted pDCs were incubated with 0.06 TCID50 BTV8/
cell for 1 h at 37°C, washed carefully four times in culture medium to
remove unbound virus, and lysed either right away or after 48 h of culture
for RNA extraction.
CpG-A was added at a 10-g/ml final concentration. Poly(I·C) (1
g/ml) was transfected using Lipofectamine 2000 as previously described
(30), by mixing 200 ng poly(C) with 1 l Lipofectamine 2000 that was
added to the 200-l/well culture. Formol-inactivated influenzavirus
(PR8/34)was used at a 4-g/ml dose. Chloroquine, bafilomycinA1,A151,
C16, JNK, and ERK (extracellular signal-regulated kinase) inhibitors were
added to cells 30 min before stimulation, and cells were incubated over-
night after adding the activators. MyD88 inhibitory and control peptides
were incubated overnight with LD PBMCs. Thereafter, cells were stimu-
lated with CpG-A (10 g/ml) and UV-BTV8 (0.06 TCID50/cell) for 12 h.
After the stimulation period, cell supernatants were collected and kept at
20°C until IFN-/measurement.
Immunolabeling of cell subsets for analysis and/or sorting. Lymph
cDCswere isolated fromLD lymph cells by positive immunomagnetic cell
sorting (Myltenyi Biotech) as previously described using an anti-CD11c
primary antibody (27). Lymph pDCs were selected from LD lymph cells
using immunomagnetic cell selection as described before (52). For pDC
staining and/or sorting by flow cytometry, LD PBMCs were saturated for
20min on ice in FACSmedium and surface staining was performed using
primary antibodies (2 g/ml) against B cells (DU2-104 clone, IgM), CD8
cells (7C2 clone, IgG2a), TCR/ (T cell receptor gamma/delta) cells
(CC15 clone, IgG2a), CD11b cells (ILA-130 clone, IgG2a), CD11c cells
(BAQ153A clone, IgM), and CD45RB cells (CC76 clone IgG1). After
washing, cells were incubated with cyanin 5 or phycoerythrin (PE)-con-
jugated goat anti-mouse isotype-specific antibodies (Caltag) for 20 min
on ice. Cells were washed in FACS medium and resuspended in Hanks’
balanced salt solution (HBSS) plus 1% heat-inactivated FCS for cytom-
etry sorting or in phosphate-buffered saline (PBS) for FACS analysis.
Blood pDCs were sorted as B CD8 CD11b TCR/ CD11c
CD45RB	 FSChigh cells based on their capacity to produce IFN-/ upon
CpG-A stimulation (see Fig. S1 in the supplemental material).
For staining with two monoclonal antibodies (MAbs) of the same
isotype (IgG1) that needed to be distinguished (i.e., costaining of cDCs
and pDCs and CD80/CD86 labeling on pDCs), LD PBMCs were first
labeled at 4°C with the anti-CD45RB IgG1MAb (2 g/ml), followed by a
saturating concentration (50 g/ml) of fluorescein isothiocyanate
(FITC)-donkey Fab anti-mouse IgG (Jackson ImmunoResearch). After
two washes in FACS medium, cells were incubated with the second IgG1
primary MAb (i.e., anti-CD11c [OM1 clone] or anti-CD80 [ILA-159
clone] plus anti-CD86 [ILA-190 clone]) and with the anti-B (DU2-104
clone, IgM), anti-CD8 (7C2 clone, IgG2a), anti-TCR/ (CC15 clone,
IgG2a), anti-CD11b (ILA-130 clone, IgG2a), and anti-CD11c (BAQ153A
clone, IgM). These primary antibodies were detected with PE-conjugated
goat anti-mouse IgG1 andCy5-conjugated goat anti-mouse IgG2a or IgM
(Molecular Probes). Blood cDCs were sorted from LD PBMCs as B
CD8 CD11b TCR/ CD45RB CD11c	 FSChigh cells.
For NS2 detection in BTV-infected pDCs, cellular fixation and per-
meabilization were performed using the Fix & Perm Kit (Caltag) and
intracellular NS2 was revealed with a rabbit serum against NS2 (1:500) as
described previously (27).
Nonrelevant antibodies (IgG1, IgG2a, IgM, and rabbit nonimmune
serum) were consistently used as controls to measure the level of nonspe-
cific background signal caused by primary antibodies.
Cell viability was determined by staining nonviable cells with 7-amino
actinomycin D (7-AAD; 2 g/ml), and flow cytometry analysis was per-
formed to measure the percentage of surviving (7-AAD-negative) cells.
The pDCs and cDCs (between 2 105 and 5 105 per 500ml of blood
collected) were sorted by flow cytometry on the ImaGif cytometry plat-
formusing the analyzer-sorterMoFloXDP cytometer and the Summit 5.2
software from Beckman Coulter (purity of
98%). Due to the low num-
ber of purified pDC that could be obtained, only single experimental
points could be done per sheep. The validity of the results was demon-
strated by repeating these single experimental points using different sheep
(see figure legends). The flow cytometry analysis of NS2 and CD80/86
expression in pDCs was done using a FACSCalibur cytometer (Becton
Dickinson) with the CellQuest Pro and/or FlowJo software.
IFN-/ detection (bioassay) and ruminant IFN- ELISA. IFN-/
in cell supernatants, lymphfluids or serawas quantified using a cytopathic
reduction bioassay with MDBK cells challenged with vesicular stomatitis
virus. An internal IFN- reference was included as described elsewhere
(52). Each supernatant was tested over eight serial dilutions. Data are
expressed as IFN-/ units per ml. A specific bovine/ovine IFN- en-
zyme-linked immunosorbent assay (ELISA) was used as described previ-
ously using anti-bovine IFN- 1C6 and 1D10 MAbs and rabbit anti-bo-
vine IFN- IgG (52).
Cytokine mRNA detection by qRT-PCR. Total RNA was extracted
using the Arcturus PicoPure RNA isolation kit (Arcturus). To exclude
DNA contamination, RNA samples were treated with RNase-free DNase
(Qiagen). cDNA was prepared using SuperScript III RT (Invitrogen).
Quantitative real-time PCR was done using 5 ng cDNA with 300 nM
primers in a final reaction mixture volume of 25 l 1 SYBR green PCR
master mix (Applied Biosystems) using an Eppendorf Mastercycler ep
realplex system.
The primers used were glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (forward, CACCATCTTCCAGGAGCGAG, and reverse, CCA
GCATCACCCCACTTGAT), IFN- (forward, TCTGCAAGAGAAGGG
ACACA, and reverse, CCTGCAAGTTTGTTGAGGAAG), tumor necro-
sis factor (TNF) (forward, CAAGGGCCAGGGTTCTTACC, and reverse,
GCCCACCCATGTCAAGTTCT), IL-6 (forward, GCTGCTCCTGGTGA
TGACTTC, and reverse, GGTGGTGTCATTTTTGAAATCTTCT), and
IL-12 (forward, TCTCGGCAGGTGGAAGTCA, and reverse, ACTTTGG
CTGAGGTTTGGTCTG). Quantitative analysis was performed using the
Realplex software (Eppendorf). Cytokine mRNA levels relative to the
amount of GAPDHwere calculated by analyzing the cycle threshold (CT)
values for each amplification curve, and the arbitrary units were estab-
lished by the formula 2[CT(target)  CT(GAPDH)].
Viral RNA detection was done using a commercial pan-BTV real-time
RT-PCR (Adiavet BTV real-time A352; Adiagene, France) targeting seg-
ment 10 of BTV, which is highly conserved among BTV serotypes.
Statistical analyses. Due to the low numbers of purified pDCs that
could be collected from 500ml of blood in many instances, replicates and
statistics could not be done within an experiment, but the experiments
were repeated with different animals. When replicates were possible, data
were expressed asmeans standard errors of themeans (SEM). Statistical
significance of differences was determined by paired or unpaired Stu-
dent’s t tests, by a paired one-tail Wilcoxon test, or by a Kruskal-Wallis
test. The test used is mentioned in the figure legends (in the figures, one
asterisk shows a P value of 0.05 and two asterisks show a P value of
0.005). Differences were considered statistically significant for P values
of 0.05. Statistical analyses were performed using GraphPad Prism 5
software.
RESULTS
Administration of BTV in sheep induces IFN-/ in afferent
skin lymph and in blood. We first examined whether BTV in-
duces IFN-/ in vivo in sheep. We took advantage of the possi-
bility to sequentially collect afferent skin lymph in this species
after virus inoculation in the skin (10, 27). Inoculation of attenu-
ated BTV2 (a-BTV2) and wild-type BTV8 (BTV8) in the skin in-
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duced IFN-/ production in lymph, peaking at day 6 with a-
BTV2 (16 IU/ml) and at day 5 with BTV8 (12 IU/ml), which
corresponds to the peak of viral dissemination by cDCs from skin
(27) (Fig. 1A and B). IFN-/ (Fig. 1A and B) and BTV (data not
shown) were undetectable in lymph by day 10. We also found
circulating IFN-/ in the blood of sheep inoculatedwith BTV8 at
days 2 and 6 postinjection (Fig. 1C). IFN-/ reached basal levels
in blood at day 10 postinjection. The viral load in blood peaked at
day 6 (around 106 viral RNA copies/ml) and was decreased by
10-fold at day 10 (data not shown).
BTV induces IFN-/ synthesis byLD lymphandblood cells
independently of BTV strain and attenuation. Based on the data
obtained as described above (Fig. 1), we hypothesized that lymph
and blood pDCs and/or cDCs (the latter being early BTV targets
[27]) could be activated by BTV to produce IFN-/. As a first
approach, we simply enriched lymph and blood cells in cDCs and
pDCs by low-density (LD) gradient centrifugation.We found that
a rather low dose and wide range of BTV8 TCID50 per cell [(1 to
50)  102] was efficient at triggering IFN-/ synthesis in LD
lymph and blood cells (Fig. 2A). The amount of IFN-/ in the
cell supernatant varied among animals (over 30 animals tested).
Twenty-six BTV serotypes exist. We tested whether IFN-/ in-
duction would depend on viral strain and/or attenuation (vaccine
strain). We used BTV strains that are representative of serotypes
that have circulated in Europe since 2001, i.e., BTV1, -8, and -2. It
was clear from our data that wild-type BTV2, BTV8, BTV1, and
a-BTV2 each triggered IFN-/ production by LD PBMCs, with
no significant differences between strains (Fig. 2B).
pDCsare themainproducersof IFN-/ in lymphandblood
cells. We proceeded to identify the cell type that was responsible
for the IFN-/ produced by the LD lymph and blood cells after
BTV stimulation. In sheep lymph, cDCs are CD11c	 cells and
pDCs are characterized as BCD11cCD45RB	 cells, which can
be isolated using immunomagnetic beads as previously described
by us (52). No IFN-/ could be detected in response to a-BTV2
in the lymph CD11c	 cell fraction, while substantial amounts
were found in the CD11c cell fraction (500 IU/ml) (Fig. 3A).
Lymph pDCs were isolated as described previously (52) and were
found to produce IFN-/ upon exposure to CpG-A (10,000
U/ml), poly(I·C)—a synthetic dsRNA analogue—in Lipo-
fectamine 2000 (120 U/ml), and a-BTV2 (1,000 U/ml). Con-
versely, CD11c	 and B CD11c CD45RB LD lymph cells were
found to be unresponsive to CpG-A and Lipofectamine-trans-
fected poly(I·C) (Fig. 3B and not shown). A specific anti-sheep
IFN- ELISA confirmed that BTV induced bona fide IFN- in
sheep lymph pDCs (Fig. 3C). In order to extend these results to
blood cells, we purified CD45RB	 and CD45RB cells from LD
PBMCs and confirmed that the IFN-/ production in response
to BTV was confined to the CD45RB	 blood cell fraction (Fig.
3D). We then set up our goal to sort sheep blood pDCs to a high
purity level using flow cytometry sorting. As shown in Fig. S1 in
the supplemental material, upon CpG-A stimulation, IFN-/-
producing cells were exclusively found among theCD45RBhigh B
CD11b TCR/ CD8 CD11c cells (see Fig. S1A to C). Fur-
thermore, we separated the CD45R RBhigh B CD11b TCR/
FIG 1 BTV induces IFN-/ in afferent skin lymph (A and B) and in serum (C) in vivo. (A and B) Two cannulated sheep were inoculated intradermally with 105
TCID50 a-BTV2 (A) and BTV8 (B), respectively. Afferent lymph was collected sequentially, and IFN-/ was measured in the lymph fluid (U/ml) using a
bioassay. (C) Sheep (n 5) were infected intravenously and subcutaneously with 1 and 5 ml blood, respectively, from a BTV8-infected viremic sheep. IFN-/
in sera was measured using a bioassay. Significant differences between groups are indicated (*, P 0.05; unpaired t test).
FIG 2 BTV induces IFN-/ synthesis in LD skin lymph cells and LD PBMCs
in vitro independent of viral strain and attenuation. (A) LD skin lymph cells
and LD PBMCs from the same animal (1.5 106/ml) were cultured overnight
with increasing doses of BTV8. The results of 1 representative experiment out
of 5 are shown. (B) LD PBMCs from 5 sheep (1.5  106/ml) were cultured
overnight with BTV strains BTV1, a-BTV2, BTV2, and BTV8 (0.06 TCID50/
cell). Culture supernatants were collected, and IFN-/was measured using a
bioassay (U/ml). Means  SEM are shown. There were no significant differ-
ences in IFN-/ induction between strains (P 0.6; Kruskal-Wallis test).
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CD8 CD11c cells into small-, intermediate-, and large-sized
cells (fractions 1, 2, and 3, respectively) based on the forward
scatter (FSC) profile. As shown in Fig S1C, only fraction 1 (FSChigh
cells) produced IFN-/ in response to CpG. Fraction 1 also ex-
pressed high levels of the critical pDC transcriptional regulator
TCF4 (9), much higher than cDCs did (see Fig. S1D). However,
high TCF4 RNA levels were also found in fractions 2 and 3
(FSClow) that do not produce IFN-/. These TCF4	 CD45RB	
FSClow cells could correspond to mature pDCs that are smaller
than immature pDCs and that do not respond to CpG-A in mice
(5). We thus decided to sort “responsive” blood pDCs based on
the CD45RBhigh BCD11b TCR/ CD8 CD11c FSChigh
phenotype in the subsequent studies. Blood cDCs were sorted as
being CD11c	 B CD11b TCR/ CD8 CD45RB FSChigh
cells based on previously published phenotypic studies (3). From
a sheep blood sample (400 ml), between 1 and 5  105 pDCs or
cDCs could be sorted to high purity, which allowed us to under-
take functional studies. When highly purified sheep blood pri-
mary pDCs and cDCs were sorted and stimulated with BTV8 or
CpG-A, only pDCs produced IFN-/ (Fig. 3E). As for lymph
pDCs, we observed that the level of IFN-/ produced by blood
pDCs upon BTV stimulation was lower than that induced by
CpG-A (Fig. 3A and E).
BTV infects pDCs but BTV replication is not mandatory for
IFN-/ synthesis in pDCs. IFN-/ production by pDCs does
not usually require viral replication but exceptions do exist (25,
30). Rotaviruswas found to infect a small fraction of human blood
primary pDCs, but IFN-/ induction by rotavirus was found to
be replication independent (11). We found that pDCs from
BTV8-infected LD PBMC cultures (27%) were expressing the
nonstructural NS2 protein, indicating that active viral infection
occurs in sheep pDCs (Fig. 4A). Furthermore, when highly puri-
fied sheep blood pDCs were infected with BTV8, accumulation of
viral RNA was detected after 48 h of culture (Fig. 4B). We then
inactivated BTV8 using UV irradiation for different periods of
time (see Fig. S2 in the supplementalmaterial). After 20min ofUV
irradiation of the viral inoculum (UV-BTV), viral replication
could not be detected in LD lymph cells that included over 30%
cDCs, the primary BTV target for viral replication, and around 2%
pDCs (see Fig. S2A). However, IFN-/was still found to be pro-
duced in the supernatant of LD lymph cells (see Fig. S2B), al-
though at a lower level than with live virus. IFN-/ synthesis was
further decreased with an increased duration of UV exposure,
suggesting that UV treatment may possibly alter viral structures
important for sensing in pDCs. Viral replication of UV-BTV8 (20
min of irradiation) could not be detected in BHK21 cells either
(data not shown). UV-BTV preparations from 4 strains stimu-
lated LD PBMCs to produce IFN-/, although at a significantly
lower level than live BTV did (see Fig. S2C). Heat-inactivated
preparations were inefficient (see Fig. S2C). We confirmed that
UV-BTV did not replicate in pDCs from BTV-infected LD PBMC
cultures (Fig. 4A) or in the purified pDCs (Fig. 4B). There again,
UV-BTV8 still induced IFN-/ in highly purified blood pDCs,
although to a lower extent than live BTV8 (Fig. 4C).
BTV is a very difficult virus to purify, and therefore, crude
BTV-infected BHK21 cell supernatants were used to stimulate
pDCs in the above-described experiments. We nevertheless suc-
cessfully purified BTV1 by sucrose gradient centrifugation (46)
FIG 3 pDCs from lymph (A to C) and blood (D and E) are the main hematopoetic cell type producing IFN-/ in response to BTV in vitro. (A) CD11c	 and
CD11c cells were sorted from LD lymph cells with magnetic-activated cell sorting (MACS)-immunomagnetic beads and cultured (106/ml) overnight alone or
with a-BTV2 (0.01 TCID per cell) or CpG-A (10g/ml). IFN-/wasmeasured using a bioassay (U/ml). (B)MACS-sorted BCD11cCD45RB	 (pDCs) and
control BCD11cCD45RB LD lymph cells were cultured overnight (105/ml) with lipofected poly(I·C) (200 ng plus 1l Lipofectamine 2000), a-BTV2 (0.01
TCID50/cell), or CpG-A (10 g/ml). IFN-/ production was measured using a bioassay (U/ml). (C) MACS-selected B
 CD11c CD45RB	 and control B
CD11c CD45RB LD lymph cells (105 cells/ml) were cultured overnight with a-BTV2 (0.01 TCID50/cell), and IFN- was measured in cultured supernatant
using a ruminant-specific IFN- ELISA. (D) MACS-sorted CD45RB	 and CD45RB cells from LD PBMCs (1.5 106 cells/ml) were cultured overnight with
BTV8 (0.06 TCID50/cell) or CpG-A (10g/ml). IFN-/was measured using a bioassay. (E) Blood pDCs (B
CD8CD11bCD11cCD45RB	 FSChigh) and
blood cDCs (B CD8 CD11b CD45RB CD11c	 FSChigh) were sorted at 98% purity by flow cytometry (2.5 105 cells/ml) and stimulated overnight with
BTV8 (0.06 TCID50/cell) and CpG-A (10 g/ml). IFN-/ was determined in supernatants using a bioassay. Each experiment was repeated at least one or two
times, and similar results were obtained. Note that due to the low numbers of purified pDCs that could be collected from 500ml of blood inmost instances, only
single experimental pDC points could be done per animal. The results were confirmed by repeating the experiment with several animals.
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and found that purified BTV1 and UV-BTV1 both induced IFN-
/ in highly purified sheep blood pDCs (Fig. 4D), indicating that
cell culture contaminants were not responsible for IFN-/ in-
duction in pDCs. Lymph pDCs were also induced to produce
IFN-/ upon UV-a-BTV2 stimulation. However, as found with
LD PBMCs (see Fig. S2C in the supplemental material), heat-
inactivated BTV (Fig. 4E) and binary ethyleneimine-inactivated
BTV from a commercial vaccine (without adjuvant; data not
shown) were not capable of IFN-/ induction in pDCs, suggest-
ing that specific structural viral motifs need to be preserved to
ensure proper sensing for IFN-/ induction in pDCs.
BTV induces the expression of several cytokine genes in ad-
dition to IFN-, as well as surface CD80/86, in primary sheep
blood pDCs. Since pDCs have been shown to produce other cy-
tokines besides IFN-/ in mice and humans, we determined
whether other cytokines, which are likely to have a strong impact
on the immune response triggered by the virus, were induced by
BTV in sheep pDCs. Indeed, live purified BTV1, UV-BTV1, and
crude UV-BTV8 were all found to induce IFN-, TNF-, IL-6,
and IL-12 gene expression in purified sheep blood pDCs (Fig. 5B
andC). UV-BTV8was also found to increase the expression of the
costimulatory CD80/86 molecules on the cell surface of the pDCs
from LD PBMC cultures (Fig. 5A, median fluorescence intensity
of 66 for unstimulated and 172 for BTV-activated pDCs).
IFN-/ induction by UV-BTV in purified pDCs involves
endo-/lysosomal maturation. So far, our data have shown that
BTV triggers IFN-/ secretion, as well as the expression of other
cytokine genes and costimulatory molecules, in primary sheep
pDCs by a mechanism that does not require viral replication. In
order to investigate the mechanism of IFN-/ induction in
pDCs, we used UV-BTV stimulation to avoid possible interfer-
ence between IFN-/ synthesis and viral replication. We first
addressed whether IFN-/ induction by UV-BTV required in-
tracellular processing via endo-/lysosomal vesicle maturation.We
used bafilomycin A1, an ATPase-specific inhibitor that blocks en-
dosomal and lysosomal acidification. We found that bafilomycin
A1 abrogated the IFN-/ production by LDPBMCs and purified
pDCs that were stimulated with either UV-BTV8 or CpG-A (Fig.
6A and B). Chloroquine, which is largely used as an inhibitor of
endo-/lysosomal maturation, also prevented the IFN-/ synthe-
sis induced by UV-BTV in LD PBMCs and in highly purified
blood pDCs. However, chloroquine did not affect the IFN-/
synthesis induced by poly(I·C) delivered with Lipofectamine
2000, which accesses the cytosol without need for endosomal
routing (69) (Fig. 6C and D). Cell viability was found to be unal-
tered by these drug treatments (see Fig. S3A and B in the supple-
mental material).
IFN-/ induction by UV-BTV involves TLR7-independent
andMyD88-dependent signaling. The inhibition of IFN-/ in-
duction by inhibitors of endolysosomalmaturation suggests that a
TLR-mediated signaling may be involved in the IFN-/ induc-
tion by UV-BTV, as is usually the case with pDCs stimulated by
viruses. TLR7 is known to mainly sense single-stranded viral
RNAs, but it was shown to also respond to specific tertiary dsRNA
structures (29). We therefore tested the effect of A151, an oligo-
nucleotide described as a TLR antagonist that inhibits TLR7 and,
to a lesser extent, TLR9. A151 at a 50-g/ml concentration po-
tently inhibited the synthesis of IFN-/ induced in sheep LD
PBMCs by inactivated influenzavirus and, to a lesser extent, by
CpG-A, as expected. However, even at a 50-g/ml concentration,
A151 did not inhibit the IFN-/ induction by UV-BTV (Fig. 7).
As A151 strongly inhibited influenza virus-induced IFN-/ that
can signal through TLR7 and -8, this implies that UV-BTV acti-
FIG 4 BTV replicates in pDCs but replication is dispensable for IFN-/ induction. (A) LD PBMCs were infected with BTV8 or UV-BTV8 (0.06 TCID50/cell)
or were left untreated and were incubated for 48 h at 37°C. The B	 CD8	 TCR/	 CD11b	 CD11c	 cells were gate excluded, and the CD45RB	 FSChigh cells
were analyzed for NS2 expression (% shown). NS2-specific expression was controlled with nonimmune rabbit serum (control). The experiment was reproduced
3 times with similar results. (B) FACS-sorted blood pDCs (2.5 105/ml) were cultured with BTV8 or UV-BTV8 (0.06 TCID50/cell). Total RNAwas extracted 48
h after infection. Expression of NS3-BTV RNA relative to that of GAPDH was determined by qRT-PCR, and arbitrary units were calculated using the 2CT
method (mean results SEM from 2 independent cultures). (C) FACS-sorted pDCs (2.5 105 cell/ml) were cultured alone or with BTV8 or UV-BTV8 (0.06
TCID/cell). IFN-/ was detected using a bioassay (U/ml). (D) FACS-sorted pDCs (2.5 105 cells/ml) were cultured overnight with sucrose gradient-purified
BTV1 and UV-BTV1 (3 g/ml, around 0.01 TCID/cell). The supernatants were collected, and type I IFN was measured using a bioassay (U/ml). (E) pDCs were
selected from LD lymph cells using MACS beads. They were cultured overnight (1.5  106 cells/ml) alone (mock) or with a-BTV2 (0.01 TCID50/cell),
UV-inactivated a-BTV2 (0.01 TCID50/cell), or heat-inactivated a-BTV2 (H-BTV2) (0.01 TCID50/cell). IFN-/was detected (U/ml) in the culture supernatant
using a bioassay.
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vates IFN-/ production via a TLR7/8-independentmechanism.
Note that bovine pDCs do not express TLR8 mRNA (20).
Although TLR7 did not appear to play any role in the IFN-/
induction by UV-BTV, we asked whether the MyD88 adaptor
molecule could be involved in that process. Indeed, MyD88 not
only mediates TLR7 and TLR9 signaling but is also involved in
TLR-independent pathways of IFN-/ induction, such as in the
case of the DNA virus sensor DHX36 box helicase in pDCs (36).
As RNA interference cannot be used in primary pDCs, in which
these molecules induce IFN-/ by themselves (29), we used a
MyD88 homodimerization inhibitor peptide that binds to the
MyD88 TIR domain and that is fused to an antennapedia-derived
cell permeant motif (43). LD PBMCs from 5 different sheep were
cultured overnight with theMyD88 inhibitory peptide or the con-
trol peptide and then activated with CpG-A or with UV-BTV for
12 h. Whereas the control peptide, i.e., the antennapedia cell per-
meant motif, marginally affected the IFN-/ secretion induced
by CpG-A (87% 7% [mean SEM] of the level in the control)
andUV-BTV (83% 10% of the level in the control), theMyD88
inhibitory peptide at the 100 M dose significantly reduced the
IFN-/production induced both byCpG (28% 8%of the level
in the control) and BTV (40%  6% of the level in the control)
(Fig. 8). We could not use the MyD88 inhibitory peptide and its
control on purified pDCs for subsequent stimulation by UV-BTV
because the sorting procedure compromised the viability of the
cells and, thus, the cells did not survive the subsequent preincu-
bation with both the control and the inhibitory peptides. How-
ever, the viability of fresh LDPBMCswas not significantly affected
by the peptides (see Fig. S3C in the supplemental material). As the
only cells capable of IFN-/ production in LD PBMCs are pDCs
(Fig. 3), we can conclude that UV-BTV signaling for IFN-/
synthesis in pDCs involves, at least in part, the MyD88 adaptor,
independent of TLR7/8 activation.
IFN-/ induction by UV-BTV in pDCs implicates PKR-
and JNK-dependent signaling pathways. The cytosolic serine-
threonine kinase PKR has been implicated in the IFN-/ pro-
duction induced by viruses inmany cell types, including cDCs (13,
56), but is not yet studied in pDCs. PKR activation can occur by
direct binding of dsRNA or can be induced downstream of other
nucleic acid sensors, such as TLR (30) or, possibly, MDA-5 (56,
60). In order to assess the contribution of PKR in the IFN-/
production induced by UV-BTV, we treated LD PBMC cultures,
as well as purified blood pDCs, with 2-aminopurine (2-AP), a
commonly used PKR inhibitor (66), or with the oxindole-imida-
zole C16, a reported selective PKR inhibitor that is efficient in
different cell types from different species (2, 21, 24, 31, 33). Be-
cause anti-sheep PKR and P-PKR antibodies are not available, we
confirmed that C16 used at a 500 nM concentration was potent at
preventing PKR phosphorylation induced by poly(I·C) in HeLa
cells (data not shown). Both drugs potently inhibited IFN-/
secretion in LD PBMCs (Fig. 9A and B) while maintaining cell
viability (see Fig. S3D and E in the supplemental material). Both
FIG 5 UV-BTV increases CD80/86 surface expression and activates cytokine gene expression in blood pDCs. LD PBMCs were cultured alone (mock) or with
UV-BTV8 (0.06 TCID50/ml). Cells were stained for pDCmarkers (see Fig. 4A legend) and for CD80/86 surface detection. (A) FACS histogram of CD80/86 and
isotype control (ISC) expression on gated pDCs is presented. (B) FACS-sorted pDCs from one sheep (2.5 105 cells/ml) were cultured overnight alone or with
BTV1 (sucrose gradient purified, 3 g/ml) or UV-BTV1 (sucrose gradient purified, 3 g/ml). Cytokine gene expression relative to that of GAPDHwas assessed
by qRT-PCR, and arbitrary units were calculated by the 2CTmethod. (C) FACS-sorted pDC preparations from 3 different sheep were stimulated overnight by
UV-BTV8 (0.06 TCID50/cell), and cytokine gene expression was evaluated as described for panel B (means SEM are shown). *, P 0.05; paired t test.
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drugs also strongly reduced the IFN-a, TNF-a, and IL-12 mRNA
expression induced by UV-BTV in purified pDCs (Fig. 9D),
whereas they did not affect the CD80/CD86 expression level in-
duced by UV-BTV at the cell surface of pDCs (Fig. 9C).
As PKR was shown to modulate IFN-/ mRNA poly(A) in-
tegrity in rotavirus-infected mouse embryonic fibroblasts and in
cDCs infected with some specific RNA viruses, we tested whether
the oxindole-imidazole C16 treatment would decrease the pro-
portion of polyadenylated versus total IFN- mRNA induced by
UV-BTV. As shown in Fig. S4 in the supplemental material, C16
decreased the IFN-/mRNA amounts detected by random hex-
amer (total RNA)- and oligo(dT) (polyadenylated RNA)-primed
reverse transcription to a similar extent. Thus, blockade of PKR
enzymatic activity by C16 does not specifically affect the amounts
of polyadenylated IFN-/ mRNA in UV-BTV-treated pDCs,
suggesting that the PKR-mediated increase of IFN-/ mRNA
does not involve regulation of IFN-/mRNA polyadenylation.
PKR is known to activate mitogen-activated protein kinases
(MAPK), such as stress-activated protein kinase (SAPK)/JNK
(22), which has also been implicated in the induction of IFN-/
production by cDCs upon adenovirus stimulation (15). LD
PBMCs and purified pDCs were cultured with UV-BTV in the
presence of SP600125 (a SAPK/JNK inhibitor) (4, 12, 32, 45) and
PD184325 (an inhibitor of ERK1/2, which is another member of
the MAPK family) (64). We found that UV-BTV IFN-/ induc-
tion was inhibited by the SAPK/JNK inhibitor by over 60% (Fig.
10B), whereas the ERK1/2 inhibitor had no effect (Fig. 10A). No
toxicity was found for the SAPK/JNK inhibitor (see Fig. S3F in the
supplemental material).
Altogether, our data show that the induction of IFN-/ by
UV-BTV in pDCs involves a TLR7/8-independent and MyD88-
dependent mechanism. Based on the use of pharmacological in-
hibitors, they also implicate PKR- and SAPK/JNK-dependent
mechanisms.
DISCUSSION
Our study reveals novel information concerning the interactions
between the dsRNA virus BTV and primary dendritic cell subsets
for the induction of IFN-/, a key innate immunity cytokine that
FIG 6 UV-BTV8-induced type I IFN in blood pDCs is sensitive to bafilomycin A1 (A, B) and chloroquine (C, D). (A and B) LDPBMCs (1.5 106 cells/ml) (left)
and FACS-sorted pDCs (2.5 105 cells/ml) (right) were treatedwith bafilomycin A1 (2.5 and 10g/ml) for 30min prior toUV-BTV8 (0.06 TCID50/ml) (A) and
CpG-A (10g/ml) (B) exposure. After overnight culture, IFN-/wasmeasured (U/ml) in supernatants by bioassay. Data are expressed as the percentage of the
IFN-/ level obtained without drug. (C and D) LD PBMCs (3  105 cells/well) (left) and FACS-sorted pDCs (5  104 cells/well) (right) were treated with
chloroquine (5 and 10 g/ml) for 30 min prior to UV-BTV8 (0.06 TCID50/ml) (C) and poly(I·C) (200 ng plus 1 l Lipofectamine 2000) exposure (D). After
overnight stimulation, supernatants were collected and IFN-/wasmeasured using a bioassay (U/ml). Data are expressed as the percentage of the IFN-/ level
obtained without drug. Single experimental points from one sheep were used in panels A, B, and D and the filled (pDC) bars of panel C, and single experimental
points from three sheep LD PBMCs (means SEM) were used the empty bars in panel C. *, P 0.05; paired t test.
FIG 7 The TLR7/9 inhibitor A151 does not affect IFN-/ induction by UV-
BTV in LD PBMCs. Freshly isolated LD PBMCs were preincubated with in-
creasing doses of the TLR7/9 inhibitor A151 for 30min and further stimulated
overnight with UV-BTV8 (0.06 TCID/cell), CpG (10 g/ml), or formol-inac-
tivated influenzavirus (4 g/ml). IFN-/ was detected in supernatants by a
bioassay. The IFN-/ amounts induced by influenza virus, CpG-A, and
UBTV8 were 110, 190, and 64 IU/ml, respectively. The experiment was repro-
duced twice and gave the same results.
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is instrumental for optimal CD8 T cell and antibody responses
(39, 41, 51) and for direct antiviral defense. We showed that BTV
displays specific interactions with primary pDCs and cDCs: while
it infects both cell types, it induces IFN-/ only in pDCs without
requiring viral replication, via amechanism involving endocytosis
and signaling through the MyD88 adaptor without TLR7/8 en-
gagement. Our data show for the first time the involvement of
MyD88 in dsRNA virus signaling in pDCs. Thus, MyD88 remains
the only known transducing molecule in pDCs for type I IFN
induction. However, the evidences presented here from our BTV
study demonstrate clearly that viral sensors other thanTLR7/8 can
be used in pDCs, as was found for TLR9 with some DNA viruses
that can alternatively use the DHX36 helicase in pDCs (36).
Although IFN-/was detected in blood and lymph early after
in vivo BTV infection, it was no longer detected in lymph and
blood by day 10. BTV has disappeared in lymph at that time, but
relatively high viral loads were still detectable in blood, as previ-
ously reported by several authors (49, 53). The lack of IFN-/
detection in blood at day 10 could be related to the decreased
number of pDCs in blood that has been observed in the course of
FIG 8 Inhibition of MyD88 homodimerization reduces IFN-/ release by sheep LD PBMCs in response to UV-BTV8 and CpG-A. LD PBMCs from 4 sheep
(3 105 cells/well) were incubated overnight alone or withMyD88 inhibitory peptide or control peptide and then were stimulated for 12 h with UV-BTV8 (0.06
TCID50/ml) (A) and CpG-A (10 g/ml) (B). IFN-/ was measured (U/ml) in the supernatants using a bioassay. The IFN-/ amounts induced by UV-BTV
were 16, 31, 63, and 500 IU/ml for the 4 different sheep, respectively. The IFN-/ amounts induced by CpG-A were 62.5, 125, 250, and 1,000 IU/ml. Data are
expressed as the percentages of the IFN-/ level obtained without peptide treatment. Means SEM are shown. *, P 0.05; paired t test.
FIG 9 PKR inhibition reduces IFN-/ release and cytokine gene activation by blood pDCs in response to UV-BTV8. (A, B) 2-AP (A) and C16 (B) were used
to block PKR activation in LD PBMCs (empty bars) and FACS-sorted pDCs (filled bars). Drugs were added to cells at indicated concentrations for 30min before
infection, and cells were stimulated overnight with UV-BTV8. IFN-/ was measured (U/ml) in supernatants using a bioassay. Data are expressed as the
percentages of the IFN-/ level obtained without drug treatment. Data expressed as means SEM were obtained with 3 different sheep. *, P 0.05; paired t
test. (C) LD PBMCs were treated or not with C16 (0.5M) and were exposed to UV-BTV8 (0.06 TCID50/ml) for 48 h. Cells were stained for pDC and CD80/86
detection by FACS analysis. The histogram represents themedians of fluorescence intensity (MFI) of CD80/86 expression on pDCs. (D) FACS-sorted pDCswere
incubated with C16 (0.5 M) for 30 min prior to UV-BTV8 stimulation and cultured overnight. Cytokine gene expression (IFN-, TNF, and IL-12p40) was
determined by qRT-PCR.
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many viral infections, due to selective apoptosis (65). Among
other hypotheses, it is also possible that the association of BTV
with erythrocytes during viral clearance at day 10 prevents effec-
tive interactions between BTV and pDCs (44).
The specific induction of IFN-/ in pDCs and not in cDCs,
even with live virus, could be explained by cell type-specific mo-
lecularmechanisms, such as the expression of proper sensors, sub-
cellular trafficking, and transducing cascades. Regarding cell type-
specific sensors for IFN-/ induction by viruses, sensing of
Newcastle disease virus in cDCs largely relies on RIG-I helicase,
whereas it relies on TLR7 in pDCs (35). The lack of IFN-/
synthesis by cDCs that permit replication of BTVmay also involve
the expression of nonstructural proteins that block IFN-/ syn-
thesis. Indeed, BTV NS1 and NS2 appear to interfere with the
interferon regulatory factor (IRF-3 and -7) response in HeLa cells
(62). Following that scenario, the pDC fraction that expresses
BTV may not be producing IFN-/, as shown for rotavirus in
pDCs (11). However, we could not test whether viral expression
and IFN-/ were exclusive phenomena in BTV-infected pDCs
cultures as no anti-sheep IFN-/ antibody exists to label intra-
cellular IFN-/.
Our mechanistic investigations show that endo-/lysosomal
acidification and maturation are required for IFN-/ induction
by UV-BTV in pDCs, similar to what is found with rotavirus IFN-
/ induction in human pDCs (11). This finding indicates that an
intracellular vesicular processing of BTV is required for appropri-
ate sensing and signaling. Notably, early endosomal low pH was
also shown to be essential for BTV uncoating in mammalian cells
(17). The UV-BTV elements that are sensed for triggering IFN-
/ synthesis within pDCs could be dsRNA structures from the
core and/or proteins of the capsid. In order to test the role of
protein capsid components, we stimulated sheep pDCs with su-
crose gradient-purified virus-like particles produced from recom-
binant baculoviruses (not shown); however, the control mock
fractions of the empty baculovirus-infected insect cell cultures
also induced large amounts of IFN-/, probably due to the pres-
ence of baculovirus remnants (28). However, the protein struc-
tures may more likely be involved in the entry mechanism of the
virus and in the proper addressing to subcellular compartments
rather than in the sensing by pathogen recognition receptors. In-
deed only enveloped viruses were found capable of activating
pDCs for IFN-/ production via non-nucleic acid structures,
although this pathway is thought to be marginal compared to the
nucleic acid one (7, 16). Furthermore, in the case of rotavirus in
human pDCs, the rotaviral dsRNA encapsidated in intact virus
particles was found to be the likely signal for IFN activation (11).
However, the integrity of the capsid proteins and/or of the dsRNA
structures appeared to be very important for leading to optimal
IFN-/ production, as prolonged UV irradiation of BTV re-
duced the level of IFN production in sheep lymph cells (see Fig. S2
in the supplemental material).
The requirement for endo-/lysosomal acidification may also
indicate that BTVwas sensed in pDCs via a TLR-dependentmech-
anism. Both TLR3 (1) and TLR7 (29) can sense dsRNA. However,
TLR3 mainly plays a role in epithelial cells for IFN-/ induction
(69) and it is not expressed by pDCs inmice and humans (42, 55).
In sheep pDCs, poly(I·C) does not induce type I IFN unless it is
introduced into the cytosol by lipofection (data not shown), thus
excluding TLR3 as an endosomal dsRNA sensor. In addition, we
demonstrated that the A151 TLR7/9 inhibitor was not efficient at
blocking UV-BTV-induced IFN-/, whereas it was efficient at
blocking the IFN-/production induced by influenza virus. This
finding excludes the possibility of both TLR7 and TLR8 involve-
ment in UV-BTV signaling in pDCs.
The lack of TLR7 involvement in IFN-/ induction in pDCs
by an RNA virus as described here is a very rare event. Indepen-
dence of TLR7 has also been reported for the respiratory syncytial
paramyxovirus, which enters and signals via an unknown mech-
anism in human pDCs after plasmamembrane fusion, and not via
an endosomal pathway (30). The other known viral sensors in
pDCs are DNA sensors, i.e., TLR9 and the DHX36 helicase, which
both signal via MyD88. TLR9 is endosomal, while DHX36 is cy-
tosolic. It could be possible that UV-BTV dsRNA reaches the pDC
cytosol after uncoating and triggers (a) cytosolic helicase(s) that
remain(s) to be identified. The known RIG-1/MDA-5/LGP2/
DDX1 helicases (40, 67, 68, 69) can all bind various forms of
dsRNA, and they all signal via the mitochondrial adaptor MAVS
(also named IPS-1/Cardif/VISA) (59). However, mouse pDCs ap-
pear not to rely on MAVS for IFN-/ induction by viruses (63).
Thus, our results suggest the hypothesis that dsRNA sensors, pos-
sibly novel helicases linked to MyD88, are implicated in Reoviri-
dae-induced IFN-/ in pDCs.
PKR is the first dsRNA cell sensor that has been described. Its
autophosphorylation and dimerization upon dsRNA binding pri-
marily lead to the establishment of an antiviral state, but it can also
trigger IFN-/ synthesis in different cell types, including cDCs
(13), via multiple, complex, and sometimes controversial mecha-
nisms. In human pDCs, the PKR inhibitor 2-AP was found to
prevent the IFN-/ secretion induced by CpG-A (30), indicating
that PKR can integrate signal transduction from TLR in this cell
type. Some published reports indicate that PKR can control the
expression and activation of IRF3 and IRF1, as well as the activa-
tion of NF-B (18, 37, 38, 50), thus having an impact on IFN-/
gene transcription. In the case of rotavirus-infected embryonic
fibroblasts, PKR was shown to promote IFN-/ secretion not by
an increase of transcriptional activity but at the posttranscrip-
tional level via a yet-to-be-defined mechanism (60). Significantly,
PKR was recently found to induce IFN-/ production in coor-
dination withMDA-5 activation by some viruses via the stabiliza-
tion of IFN-/ mRNA poly(A) (56). Thus, PKR can promote
FIG 10 SAPK/JNK but not MEK1/ERK1/2 inhibition reduces IFN-/ pro-
duction in response to UV-BTV8. (A) LD PBMCs (1.5  106 cells/ml) were
treated with indicated doses of PD184352 (MEK1/ERK1/2 inhibitor) for 30
min before overnight culture with UV-BTV8 (0.06 TCID50/ml). (B) LD PB-
MCs (1.5 106 cells/ml) and pDCs (2.5 104 cells/ml) were incubated with
the SAPK/JNK inhibitor SP600125 (10 M) for 30 min before stimulation
with UV-BTV8 (0.06 TCID50/ml). IFN-/ was measured (U/ml) in culture
supernatants by bioassay. Data are expressed as the percentages of the IFN-/
level obtained without drug treatment. The results of 1 representative experi-
ment of 2 are shown.
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IFN-/ production by many mechanisms, although it has not
been studied in pDCs. In the case of BTV in pDCs, PKR activation
could be direct, via intracytosolic sensing of dsRNA, or indirect, as
for TLR signaling. Our results indicate that UV-BTV increases
IFN-/ synthesis and IFN-mRNAproduction by amechanism
independent of stabilization of mRNA polyadenylation. Finally,
possibly downstream or independently of PKR, we found that
signaling via JNK was implicated in IFN-/ production induced
by UV-BTV in primary pDCs, whereas ERK1/2 signaling was not
involved. Adenovirus that triggered IFN-/ production via TLR
and MAVS-independent mechanisms in cDCs also used JNK-de-
pendent and ERK1/2-independent signaling related to sensors
that were not identified (15).
Altogether, our data show that a dsRNA virus triggers IFN-/
in primary host pDCs via a novel mechanism that is independent
of TLR7/8 but dependent on the MyD88 adaptor. We bring some
indications that the PKR and JNK signaling pathways may also be
involved. Other members of the Reoviridae family, such as mem-
bers of the genera Rotavirus and Orbivirus, may use similar path-
ways, associatedwith a restriction of IFN-/production in pDCs
(47). Our findings aid in the understanding of BTV pathogenicity
and, importantly, will have impacts on the improvement of vac-
cine development against dsRNA viruses. For example, in order to
induce optimal adaptive immune responses, industrial processes
of viral inactivationmustmaintain the ability of BTV and/or other
reovirus particles to trigger IFN-/ production by pDCs.
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